BioSpace News Archive

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that Company’s Management will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 6th Annual NASH Investor Conference.

Palleon Pharmaceuticals today announced that the U.S. Patent and Trademark Office has issued Patent No.11,459,398 titled, “Conjugates for Targeted Cell Surface Editing.”

Enterin Inc. announces a collaboration with the Parkinson’s Virtual Biotech, the drug development and discovery arm of Parkinson’s UK. A new phase 2 trial will study the effects of ENT-01 on Parkinson’s Disease -associated dementia.

Biosense Webster, Inc., part of Johnson & Johnson MedTech†, announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter – the first radiofrequency balloon ablation catheter.

Royal Philips announced expanded rollout of its augmented reality surgical navigation solution - ClarifEye - to Japan, highlighting positive results in the first patients treated by the International University of Health and Welfare, Mita Hospital using this innovative 3D AR solution.

West Pharmaceutical Services, Inc. announced that it will release third-quarter 2022 financial results before the market opens on Thursday, October 27, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

BIOLASE, Inc., a global leader in dental lasers, announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer, effective November 1, 2022.

VectivBio Holding AG today announced positive interim data from the company’s ongoing Phase 2 STARS Nutrition study evaluating the safety, pharmacokinetics and efficacy of apraglutide, an investigational new drug that is a next-generation, long-acting synthetic GLP-2 agonist, in adult patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC).

Kira Pharmaceuticals today announced participation in the 2nd Annual Needham Biotech Private Company Virtual 1x1 Forum on October 18-19, 2022.

Bionik Laboratories Corp . today announced the appointments of Richard Russo, Jr. as Chief Executive Officer and President, who previously served as Chief Financial Officer.